Orient EuroPharma Vietnam (OEP VN) is one of the subsidiaries representing Orient EuroPharma (OEP), an innovative global science-based company of which the headquarters are located in Taipei, Taiwan.
OEP VN has been in Vietnam since 2013 with the Representative Office in HoChiMinh city. This Rep. Office was moved to Hanoi in early 2017. The move has shown very practical for reasons such as speeding up products registration, stakeholders’, influencers’ and decision making authorities’ communication and management. OEP VN started with Pitator, a drug for treating dyslipidemia, as the first OEP product to hit the Vietnam pharmaceutical market in January 2019. Moving forwards, OEP VN will keep running the sales of Pitator to the limit and introduce new dosage to the market. In the long term, OEP VN will prepare to introduce ophthalmology and anti-cancer products to enlarge the pharma market scale, as well as expanding partners and accelerating OEP brand identity in Vietnam pharmaceutical market.